SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Widman Fredrik (Last) (First) (Middle) 1020 KIFER ROAD (Street) SUNNYVALE CA 94086 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol INTUITIVE SURGICAL INC [ ISRG ] Foreign Trading Symbol	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) Other (specify below) VP Corporate Controller
	3. Date of Earliest Transaction (Month/Day/Year) 10/30/2026
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/30/2026		M(1)		546	A	$79.6378	1,572	D
Common Stock	10/30/2026		M(1)		312	A	$208.9	1,884	D
Common Stock	10/30/2026		M(1)		325	A	$139.52	2,209	D
Common Stock	10/30/2026		M(1)		307	A	$304.67	2,516	D
Common Stock	10/30/2026		M(1)		307	A	$229.39	2,823	D
Common Stock	10/30/2026		M(1)		312	A	$290.33	3,135	D
Common Stock	10/30/2026		M(1)		406	A	$347.4167	3,541	D
Common Stock	10/30/2026		M(1)		406	A	$245.6	3,947	D
Common Stock	10/30/2026		M(1)		567	A	$242.3367	4,514	D
Common Stock	10/30/2026		M(1)		567	A	$177.9867	5,081	D
Common Stock	10/30/2026		M(1)		262	A	$166.6233	5,343	D
Common Stock	10/30/2026		M(1)		263	A	$182.8333	5,606	D
Common Stock	10/30/2026		M(1)		325	A	$174.2567	5,931	D
Common Stock	10/30/2026		M(1)		543	A	$109.4856	6,474	D
Common Stock	10/30/2026		S(1)		5,448	D	$436.0551(2)	1,026	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$79.6378	10/30/2026		M(1)			546	(3)	02/15/2027	Common Stock	546	$0.0	546	D
Non-Qualified Stock Option (right to buy)	$109.4856	10/30/2026		M(1)			543	(4)	08/15/2027	Common Stock	543	$0.0	543	D
Non-Qualified Stock Option (right to buy)	$139.52	10/30/2026		M(1)			325	(3)	02/15/2028	Common Stock	325	$0.0	325	D
Non-Qualified Stock Option (right to buy)	$166.6233	10/30/2026		M(1)			262	(4)	08/15/2029	Common Stock	262	$0.0	262	D
Non-Qualified Stock Option (right to buy)	$174.2567	10/30/2026		M(1)			325	(4)	08/15/2028	Common Stock	325	$0.0	325	D
Non-Qualified Stock Option (right to buy)	$177.9867	10/30/2026		M(1)			567	(5)	02/28/2030	Common Stock	567	$0.0	567	D
Non-Qualified Stock Option (right to buy)	$182.8333	10/30/2026		M(1)			263	(3)	02/15/2029	Common Stock	263	$0.0	263	D
Non-Qualified Stock Option (right to buy)	$208.9	10/30/2026		M(1)			312	(4)	08/28/2029	Common Stock	312	$0.0	624	D
Non-Qualified Stock Option (right to buy)	$229.39	10/30/2026		M(1)			307	(6)	02/27/2030	Common Stock	307	$0.0	521	D
Non-Qualified Stock Option (right to buy)	$242.3367	10/30/2026		M(1)			567	(4)	08/28/2030	Common Stock	567	$0.0	567	D
Non-Qualified Stock Option (right to buy)	$245.6	10/30/2026		M(1)			406	(5)	02/26/2031	Common Stock	406	$0.0	406	D
Non-Qualified Stock Option (right to buy)	$290.33	10/30/2026		M(1)			312	(5)	02/28/2029	Common Stock	312	$0.0	312	D
Non-Qualified Stock Option (right to buy)	$304.67	10/30/2026		M(1)			307	(7)	08/09/2030	Common Stock	307	$0.0	521	D
Non-Qualified Stock Option (right to buy)	$347.4167	10/30/2026		M(1)			406	(4)	08/26/2031	Common Stock	406	$0.0	406	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $431.64 to $453.60 as follows: 2,650 shares sold at $431.64 to $432.57; 279 shares sold at $432.71 to $433.31; 239 shares sold at $433.85 to $434.35; 79 shares sold at $434.93 to $435.64; 321 shares sold at $435.93 to $436.73; 160 shares sold at $437.33 to $437.79; 480 shares sold at $438.76 to $439.62; 120 shares sold at $439.83 to $440.03; 160 shares sold at $440.89 to $441.86; 200 shares sold at $442.20 to $442.92; 200 shares sold at $443.37 to $444.14; 160 shares sold at $444.47 to $445.32; 240 shares sold at $445.73 to $446.59; 80 shares sold at $446.86 to $447.26; and 80 shares sold at $453.60. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range

3. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

4. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

5. Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

6. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

7. 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: Widman, Fredrik	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.